{
  "drug_name": "Digoxin",
  "url": "https://wikem.org/wiki/Digoxin",
  "scraped_at": "2026-01-10T07:51:57.125231",
  "sections": {
    "General": {
      "text": "Type: Cardiac glycoside;\nCHF medications\nMechanism of action- Inhibits Na+/K+ ATPase, leading to an increase in intracellular sodium that can increase cardiac contractility\nDosage Forms: PO, IV, IM\nCommon Trade Names: Digitek, Digox, Lanoxin",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "CHF medications",
          "url": "https://wikem.org/wiki/CHF_medications"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "Loading dose = 0.25mg IV q2hr until effect (max total = 1.5mg)\nin acute\natrial fibrillation with RVR\nwith heart failure = 0.5mg IV, then 0.25mg IV q4hr until effect or max 1.5mg",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "atrial fibrillation with RVR",
          "url": "https://wikem.org/wiki/Atrial_fibrillation_with_RVR"
        }
      ]
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n:\nRenal Dosing\nAdult\nPediatric\nHepatic Dosing\nAdult\nPediatric",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Indications": {
      "text": "RVR control in a-fib/flutter, PSVT",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nWPW\nIncreases conduction velocity in atrial tissue",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "WPW",
          "url": "https://wikem.org/wiki/WPW"
        }
      ]
    },
    "Adverse_Reactions": {
      "text": "Digoxin toxicity\nGI: nausea and vomiting, diarrhea, abdominal pain\nCV: Bradycardia, SA/AV block, ventr arrhythmias\nNeuro:\naltered mental status\n, visual disturbances (yellow-tinted vision)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Digoxin toxicity",
          "url": "https://wikem.org/wiki/Digoxin_toxicity"
        },
        {
          "text": "altered mental status",
          "url": "https://wikem.org/wiki/Altered_mental_status"
        }
      ]
    },
    "Pharmacology": {
      "text": "Onset of action\nIV = 5-30 minutes\nPO = 0.5-2 hours\nHalf-life: 36-48 hours (may be increased with renal impairment)\nAbsorption: 60-80% absorption after oral administration\nMetabolism: ~16% is converted to metabolites\nExcretion: Almost entirely by the kidneys",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Inhibits Na+/K+ ATPase in the myocardium\n[1]\nCauses increase in intracellular sodium levels\nResults in reversal of sodium-calcium exchanger\nNormally imports three extracellular sodium ions into the cardiac myocyte in exchange for one intracellular calcium being exported\nSodium accumulates intracellularly and is exchanged for Calcium.\nCauses an increase in the intracellular calcium concentration increasing contractility\nAlso a lengthening of phase 4 and phase 0 of the cardiac action potential which ultimately decreases heart rate\nSummary\nInhibits NaK pump\nPositive inotropy\nNegative chronotropy/dromotropy\nIndirect vagal stimulator",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Digoxin Toxicity\nAntiarrhythmics",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Digoxin Toxicity",
          "url": "https://wikem.org/wiki/Digoxin_Toxicity"
        },
        {
          "text": "Antiarrhythmics",
          "url": "https://wikem.org/wiki/Antiarrhythmics"
        }
      ]
    }
  }
}